PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL TO SUPPORT OPHTHALMIC SUSPENSIONS DEVELOPMENT.

被引：0
|
作者：
Le Merdy, M. [1 ]
Fan, J. [1 ]
Babiskin, A. H. [1 ]
Zhao, L. [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2019年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PBPK-011
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [21] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR FLUORIDE UPTAKE BY BONE
    RAO, HV
    BELILES, RP
    WHITFORD, GM
    TURNER, CH
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) : 30 - 42
  • [22] A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles
    Fallon, MS
    Varshney, M
    Dennis, DM
    Chauhan, A
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2004, 31 (05) : 381 - 400
  • [23] Physiologically-based pharmacokinetic modeling of genistein in rats, part I: Model development
    Schlosser, PM
    Borghoff, SJ
    Coldham, NG
    David, JA
    Ghosh, SK
    RISK ANALYSIS, 2006, 26 (02) : 483 - 500
  • [24] Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
    Claassen, Karina
    Thelen, Kirstin
    Coboeken, Katrin
    Gaub, Thomas
    Lippert, Joerg
    Allegaert, Karel
    Willmann, Stefan
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (39) : 5688 - 5698
  • [25] Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits
    Bussing, David
    K. Shah, Dhaval
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2020, 47 (06) : 597 - 612
  • [26] Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits
    David Bussing
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2020, 47 : 597 - 612
  • [27] A Physiologically-Based Pharmacokinetic Model of Drug Detoxification by Nanoparticles
    Marissa S. Fallon
    Manoj Varshney
    Donn M. Dennis
    Anuj Chauhan
    Journal of Pharmacokinetics and Pharmacodynamics, 2004, 31 : 381 - 400
  • [28] Development of a physiologically-based pharmacokinetic model to simulate the pharmacokinetics of intramuscular antiretroviral drugs
    Bettonte, Sara
    Berton, Mattia
    Battegay, Manuel
    Stader, Felix
    Marzolini, Catia
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (05): : 781 - 794
  • [29] Development of a Preclinical Physiologically-Based Pharmacokinetic Model for 161Tb-DOTATATE
    Henriot, J.
    Struelens, L.
    Andersson, M.
    Spoormans, K.
    Koole, M.
    Vargas, C. Saldarriaga
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S832 - S832
  • [30] Physiologically-based pharmacokinetic simulation modelling
    Grass, GM
    Sinko, PJ
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (03) : 433 - 451
12345